Skip to main navigation

Monte Rosa

4634 M

45°56′12.6″N

07°52′01.4″E

Approach
QuEEN / Pipeline
Our Team
Careers
Newsroom
Media / Investors

INVESTORS

Events & Presentations

Photo a person pointing on a computer screen

Investors

Overview
News & Events
- Press Releases
- Events & Presentations
Stock Information
- Stock Quote & Chart
Analyst Coverage
Corporate Governance
Financials & Filings
- SEC Filings
IR Resources

Presentations

AACR 2023 - Development of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for the treatment of lung cancers with MYC-induced translational addiction 4.3 MB

AACR 2023 - Discovery of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for MYC-driven cancers 4.4 MB

MRT-2359 KOL Webinar, October 24, 2022 4.5 MB

34th EORTC-NCI-AACR Symposium 4.1 MB

5th Annual TPD Summit - Preclinical and Mechanism of Action Studies of MRT-2359 5.1 MB

5th Annual TPD Summit - AI Applications for Molecular Glue Degraders 9.2 MB

American Association for Cancer Research Annual Meeting, April 8-13, 2022 1 MB

2nd Annual TPD Europe Summit Presentation 3.9 MB

4th Annual Targeted Protein Degradation Summit Presentation 4.8 MB

AACR-NCI-EORTC Late Breaking Presentation 2.1 MB

European Protein Degradation Congress 2021 Presentation 3.8 MB

Upcoming Events

Jefferies Healthcare Conference

Jun 8, 2023 at 4:30 PM EDT

Click Here for Webcast

Add to Google Calendar

Recent Events

More events are coming soon.

Past Events

Citi’s 17th Annual BioPharma Conference 2022

Sep 8, 2022

Wells Fargo 17th Annual Healthcare Conference 2022

Sep 7, 2022

Jefferies Healthcare Conference

Jun 9, 2022 at 4:30 PM EDT

Click Here for Webcast

Pagination

First page
Previous page
Page 1
Current page 2

HEAD OFFICE / LAB

BOS

645 Summer Street
Boston, MA 02210
United States
617-949-2643

OFFICE / LAB

BSL

Monte Rosa Therapeutics AG
WKL-136.3
Klybeckstrasse 191
4057 Basel, Switzerland

MONTE ROSA THERAPEUTICS ©2023

info@monterosatx.com

Privacy Policy Terms of Use